Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/23690
Title: Engineering of an efficient and enantioselevtive biocatalyst for the preparation of chiral pharmaceutical intermediates
Authors: TANG WENG LIN
Keywords: Directed evolution, P450, Protein engineering, Enantioselectivity, Hydroxylation, Mutagenesis
Issue Date: 17-Aug-2010
Citation: TANG WENG LIN (2010-08-17). Engineering of an efficient and enantioselevtive biocatalyst for the preparation of chiral pharmaceutical intermediates. ScholarBank@NUS Repository.
Abstract: This Ph.D. thesis focuses on the engineering of an efficient and enantioselective biocatalyst via direct evolution and genetic engineering for the enantioselective hydroxylation of non-activated carbon atom, a useful but challenging reaction for the synthesis of chiral pharmaceutical intermediates. Our target enzyme is the novel P450pyr enzyme from Sphingomonas sp. HXN-200 that was found to catalyze the regio- and stereoselective hydroxylation of non-activated carbon atom with broad substrate range, high activity, excellent regioselectivity, and good to excellent enantioselectivity. Our target reaction is the enzymatic hydroxylation of N-benzyl pyrrolidine to its corresponding (R)- and (S)-N-benzyl-3-hydroxypyrrolidines which are important pharmaceutical intermediates. In this thesis, a two-enzyme-based colorimetric high-throughput ee screening assay and a mass spectrometry-based high-throughput ee screening assay were developed. The P450pyr monooxygenase was engineered by directed evolution for the enantioselective hydroxylation of N-benzyl pyrrolidine. Several mutants exhibiting increased and/or inverted enantioselectivity were identified, with product ee of 83% (R) and 65% (S) for mutants 1AF4A and 11BB12, respectively. The wild type P450pyr and its mutants were also purified and reconstituted with their auxiliary electron transport proteins, ferredoxin and ferredoxin reductase in vitro. The mutants were then used to catalyze the hydroxylations of a range of different substrates using whole-cell assays to investigate the changes in product ee. In addition, an efficient biocatalytic system with cofactor recycling was developed by co-expressing a glucose dehydrogenase from Bacillus substilis or a phosphite dehydrogenase from Pseudomonas stutzeri together with the P450pyr system in a recombinant Escherichia coli.
URI: http://scholarbank.nus.edu.sg/handle/10635/23690
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
TangWL.pdf5.11 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

303
checked on Nov 17, 2018

Download(s)

255
checked on Nov 17, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.